Clinical trial
Stenting and Angioplasty With Protection in Patients at High Risk for…
NCT00231270 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00231270 |
|---|---|
| Title | Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) |
| Official title | Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carotid Artery Disease |
| Intervention type | Device |
| Interventions | Cordis Nitinol Stent, PRECISE tapered stent, ANGIOGUARD XP Emboli Capture Guidewire (ECGW) |
| Enrollment | 1,300 |
| Start date | Aug 1, 2000 |
| Completion | Aug 1, 2005 |
| First posted | Oct 4, 2005 |
| Last update posted | Apr 24, 2008 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: